Abstract Library

#4331 Amino acid-induced hyperkalaemia during peptide receptor radionuclide therapy (PRRT): A case report and literature review

Introduction: PRRT an established treatment for neuroendocrine tumours (NETs). Therapy requires prophylactic positively charged amino acid (AA) co-infusion to reduce renal radiation exposure. AA infusion has been associated with metabolic acidosis and electrolyte abnormalities, particularly hyperkalaemia; comprehensive data on the prevalence and severity of these complications remains limited.

Conference:

Presenting Author:

Authors: Osher E, Wolf I, Geva R, Sofer Y, Greenman Y,

Keywords: PRRT, hyperkalaemia, amino acid infusion, neuroendocrine tumour, adverse effects,

#3263 Prognostic factors in curative resected locoregional small intestine neuroendocrine neoplasms

Introduction: Small intestinal neuroendocrine neoplasms (SI-NEN) are rare and only about 40% of patients are diagnosed without distant metastases.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Maurer E

Authors: Bartsch D, Maurer E, Evers M, Ramaswamy A, Rinke A,

Keywords: SI-NEN, stage 3, surgery,

#3206 Efficacy and safety of peptide receptor radionuclide therapy (PRRT) in patients with chronic kidney disease (CKD)

Introduction: The kidney is a dose-limiting organ in PRRT. Most clinical studies have focused on the safety of PRRT with normal or mildly impaired kidney function.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Alsadik S, Gnanasegaran G, Chen L, Toumpanakis C, Caplin M,

Keywords: neuroendocrine tumor, peptide receptor radionuclide therapy PRRT, 177lu-DOTATATE, chronic kidney disease,

#2732 Prostate Metastasis of Medullary Thyroid Carcinoma in a Young Patient with MEN2B Syndrome

Introduction: Multiple Endocrine Neoplasia 2B is associated with particularly early onset medullary thyroid carcinoma (MTC). Metastatic MTC is the leading cause of early death in MEN2B. The usual sites of metastasis are neck, mediastinum, lung, liver, bone and brain.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Noble J

Authors: Noble J, Forde H, Crowley R,

Keywords: Neuroendocrine, MEN2B, Medullary Thyroid Cancer, Prostate Metastasis, Calcitonin, Multiple Endocrine Neoplasia,

#126 Assessment of the proliferation marker Ki-67 by endoscopic ultrasound guided-Fine Needle Aspiration (EUS-FNA) in pancreatic endocrine tumors: A comparative analysis with histology of the surgical specimen

Introduction: Assessment of the proliferative index by Ki-67 immuno-labelling is an important prognostic parameter for the biologic behavior of digestive neuroendocrine tumors, usually established on the histological specimen obtained after surgery or macro-biopsy. However, small pancreatic endocrine tumors (PET) are more and more often recognized by CT/MRI and diagnosed by EUS. The value of Ki-67 labelling index (Ki-67-LI) on fine needle aspiration (FNA) is not well-established in this setting, although regularly assessed.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Borbath I

Authors: Bernard V, Weynand B, Jouret-Mourin A, Gigot J, Hubert C,

Keywords: pancreatic endocrine tumor, endoscopic ultrasound, Ki-67, prognosis,